#  Kathleen Kean

Kathleen Kean is a counsel in the firm’s Strategic Technology Transactions and Licensing Practice and member of the Technology and Life Sciences Group. Ms. Kean represents private and public biotech, pharmaceutical, diagnostic and medical device companies in connection with intellectual property, commercial and M&A transactions. Ms. Kean’s experience includes counseling clients in connection with licensing arrangements, collaboration agreements, pre-clinical, clinical and commercial contracts, mergers and acquisitions, corporate restructuring and IP migration transactions. Further, Ms. Kean routinely acts as outside general counsel for biotech companies in managing their licensing and contract needs.

## ERFAHRUNG

## Experience

## 工作经历

  * Wave Life Sciences in the negotiation of a global strategic collaboration with Takeda in central nervous system disorders; upfront of $110 million and potentially more than $2 billion in milestone payments
  * Nimbus Therapeutics in the negotiation of a strategic alliance with Celgene Corporation in immunology
  * Fresenius Kabi in its purchase of Merck KGaA’s pipeline of biosimilar candidates for €156 million upfront and up to €500 million in milestones
  * CRISPR Therapeutics in its development and option agreement with StrideBio for developing novel AAV vectors
  * Ampersand Capital Partners and 1315 Capital in their acquisition of Genoptix, Inc., a provider of comprehensive testing solutions in hematology and solid tumor molecular profiling, from Novartis Pharmaceuticals Corporation
  * Nimbus in its sale of Nimbus Apollo and its Acetyl-CoA Carboxylase (ACC) inhibitor program to Gilead Sciences for $400 million and up to an additional $800 million in development milestone payments 
  * Dimension Therapeutics in its gene therapy research collaboration with the University of Pennsylvania 
  * Alkermes in the sale of its manufacturing facility and the manufacturing and royalty revenue associated with products manufactured at the facility and global rights to Recro Pharma, Inc., for $170 million
  * Tetragenetics in its negotiation of a collaboration with MedImmune for a multi-target ion channel drug discovery program 
  * Licensing of intellectual property assets from research institutions



Professional Experience 

Prior to re-joining Goodwin in 2014, Ms. Kean was an in-house attorney at RainDance Technologies, Inc. and was previously in-house at EMC Corporation. Ms. Kean began her legal career at Goodwin in 2004. Prior to attending law school, Ms. Kean worked as a mechanical engineer.

## Recognition

While in law school, Ms. Kean was the executive editor of the _Boston University Journal of Science & Technology Law_

  * U.S. News - Best Lawyers® 

Biotechnology Law Firm of the Year




## In The News

##  MELDUNGEN 

##  Dans les Nouvelles 

##  在新闻中 

{{news.Date}}

## Credentials

##  WERDEGANG 

##  Lettres de Créance 

##  专业资格 

###  Education 

**J.D., 2004**  
Boston University School of Law  
 _cum laude_

**B.S., 1999**  
Manhattan College  


 _magna cum laude_

###  Admissions 

#### Bar

Massachusetts 

Get In Touch

KONTAKT

Entrer en contact

联系我们

Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us. 

Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte. 

Nos clients comptent sur nous pour des services de conseil de classe mondiale, des conseils sur le travail transactionnel complexe et des litiges à enjeux élevés. Spécialisés dans les domaines de la finance, des sciences de la vie, du capital-investissement, de l'immobilier et de la technologie, nous utilisons une approche collaborative et interdisciplinaire pour résoudre les problèmes les plus complexes de nos clients. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。